SURTAVI
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
- Public sites
- 56
- Start date
- Apr 1, 2012
Duke’s Valve and Structural Heart Program evaluates and treats aortic, mitral, tricuspid, and other structural heart conditions, with cardiologists, interventional cardiologists, and cardiac surgeons working together. Care includes valve repair and replacement, open, minimally invasive, robotic, and transcatheter procedures such as TAVR and percutaneous mitral valve repair, along with imaging, monitoring, second opinions, and clinical-trial evaluation.
This description was generated by AI based on public sources. Data Sources and Methodology · Report inaccurate information
Safety and Efficacy Study of the Medtronic CoreValve® System in the Treatment of Severe, Symptomatic Aortic Stenosis in Intermediate Risk Subjects Who Need Aortic Valve Replacement (SURTAVI).
TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV-I)
Percutaneous or Surgical Repair In Mitral Prolapse And Regurgitation for ≥60 Year-olds (PRIMARY)
Portico Re-sheathable Transcatheter Aortic Valve System US IDE Trial
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation.
Chapel Hill, NC
Raleigh, NC
Raleigh, NC